Skip to content
value.today

Purigen Biosystems, Inc.

🇺🇸 Pleasanton, California, USABiotechnologyFounded 2012
Total raised
$61 M
2 rounds on record
Latest round
$34 M
Mar 2019
First round on record
Mar 2016
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Purigen Biosystems, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2019$34 MNo. 2$10 to $50 million

Purigen Biosystems, Inc.: Raise no. 2, Mar 2019

Investors in this round

16 investors had bought by the notice of Apr 6, 2021: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$34 M of $34 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barney E. Saunders,Ph.D. · Executive Officer, Director · Chief Executive Officer
  • Klint E. Rose, Ph.D. · Executive Officer · Chief Scientific Officer
  • Steve E. Reichenbach · Executive Officer · Chief Financial Officer
  • Bill W. Colston, Ph.D. · Director
  • Joseph J. Victor · Director · Executive Chairman of the Board of Directors
  • Kevin W. Corcoran · Director
  • Mira E. Chaurushiya, Ph.D. · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Reichenbach, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 6, 2021. Read the notice at the SEC.

equitySEC
Mar 2016$26 MNo. 1$10 to $50 million

Purigen Biosystems, Inc.: Raise no. 1, Mar 2016

Investors in this round

28 investors had bought by the notice of Jun 4, 2018: 28 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$26 M of $31 M offered; $4 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Barnett Saunders · Executive Officer, Director
  • Klint Rose · Executive Officer, Promoter
  • Steve W. Reichenbach · Executive Officer
  • Andrew Schwab · Director
  • Bill W. Colston · Director
  • Joseph Victor · Director
  • Mitchell W. Mutz · Director
  • Juan Santiago · Promoter

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Steve Reichenbach, Cfo. Source: SEC Form D and 2 amendments, newest notice filed Jun 4, 2018. Read the notice at the SEC.

equity, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Purigen Biosystems, Inc. chose not to state its revenue in its newest notice of a funding round (Apr 2021).

    SEC Form D · Apr 2021

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2021

That is all the official record says: Purigen Biosystems, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Purigen Biosystems, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 28 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Purigen Biosystems, Inc.
NameRoleNamed in
Barney E. Saunders,Ph.D.Chief Executive OfficerApr 2021
Klint E. Rose, Ph.D.Chief Scientific OfficerApr 2021
Steve E. ReichenbachChief Financial OfficerApr 2021
Barnett SaundersExecutive officerJun 2018
Klint RoseExecutive officerJun 2018
Steve W. ReichenbachExecutive officerJun 2018
Amy HiddessenExecutive officerOct 2017
Joseph VictorExecutive officerOct 2017
Barney E. Saunders,Ph.D.Chief Executive OfficerApr 2021
Bill W. Colston, Ph.D.DirectorApr 2021
Joseph J. VictorExecutive Chairman of the Board of DirectorsApr 2021
Kevin W. CorcoranDirectorApr 2021
Mira E. Chaurushiya, Ph.D.DirectorApr 2021
Andrew SchwabDirectorJun 2018
Barnett SaundersDirectorJun 2018
Bill W. ColstonDirectorJun 2018
Joseph VictorDirectorJun 2018
Mitchell W. MutzDirectorJun 2018
Amy HiddessenDirectorOct 2017
Klint RoseDirectorOct 2017
Juan SantiagoPromoterJun 2018
Klint RosePromoterJun 2018
Amy HiddessenPromoterOct 2017